LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 57.18 | 84.90 | 2263 | 6963 | 0.3250 | 0.6759 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 57.18 | 84.90 | 2364 | 6963 | 0.3395 | 0.6875 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.88 | 84.90 | 2045 | 7291 | 0.2805 | 0.6409 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.88 | 84.90 | 2077 | 7291 | 0.2848 | 0.6449 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.88 | 84.90 | 2295 | 7291 | 0.3147 | 0.6706 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.88 | 84.90 | 2395 | 7291 | 0.3284 | 0.6818 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.59 | 84.90 | 2144 | 7641 | 0.2806 | 0.6444 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.59 | 84.90 | 2183 | 7641 | 0.2857 | 0.6490 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.59 | 84.90 | 2438 | 7641 | 0.3190 | 0.6773 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.59 | 84.90 | 2531 | 7641 | 0.3312 | 0.6870 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.29 | 84.90 | 2213 | 7934 | 0.2789 | 0.6456 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.29 | 84.90 | 2253 | 7934 | 0.2840 | 0.6501 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.29 | 84.90 | 2461 | 7934 | 0.3102 | 0.6725 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.29 | 84.90 | 2560 | 7934 | 0.3226 | 0.6826 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.99 | 84.90 | 2235 | 8212 | 0.2722 | 0.6419 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.99 | 84.90 | 2274 | 8212 | 0.2769 | 0.6462 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.99 | 84.90 | 2629 | 8212 | 0.3201 | 0.6828 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.99 | 84.90 | 2720 | 8212 | 0.3312 | 0.6915 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.70 | 84.90 | 2382 | 8484 | 0.2808 | 0.6519 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.70 | 84.90 | 2421 | 8484 | 0.2854 | 0.6559 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.70 | 84.90 | 2729 | 8484 | 0.3217 | 0.6861 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.70 | 84.90 | 2814 | 8484 | 0.3317 | 0.6939 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.41 | 84.90 | 2398 | 8766 | 0.2736 | 0.6477 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.41 | 84.90 | 2429 | 8766 | 0.2771 | 0.6509 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.41 | 84.90 | 2852 | 8766 | 0.3253 | 0.6910 | MN20160318_Q02 | F12 |